Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125678
Filing Date
2024-11-12
Accepted
2024-11-12 17:16:58
Documents
103
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q btmd-20240930.htm   iXBRL 10-Q 3814912
2 EX-10.2 btmd-ex10_2.htm EX-10.2 336322
3 EX-31.1 btmd-ex31_1.htm EX-31.1 15976
4 EX-31.2 btmd-ex31_2.htm EX-31.2 16546
5 EX-32.1 btmd-ex32_1.htm EX-32.1 9039
6 EX-32.2 btmd-ex32_2.htm EX-32.2 9511
7 GRAPHIC img170581770_0.jpg GRAPHIC 3908
8 GRAPHIC img220571548_0.jpg GRAPHIC 40976
  Complete submission text file 0000950170-24-125678.txt   14901139

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT btmd-20240930.xsd EX-101.SCH 1764604
106 EXTRACTED XBRL INSTANCE DOCUMENT btmd-20240930_htm.xml XML 2855423
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40128 | Film No.: 241449882
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)